Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024)
Grown Rogue International (GRUSF) posted quarterly Non-Current Deferred Tax Liability of $58181.0 for Q4 2024.
Grown Rogue International (GRUSF) Non-Current Deferred Tax Liability (2024) Analysis & Trends
Grown Rogue International's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $58181.0 for Q4 2024.
- In Q4 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $58181.0; the TTM figure through Dec 2024 stood at $58181.0 (changed N/A YoY), while the FY2024 annual figure was $58181.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q4 2024 stood at $58181.0.
- The five-year high for Non-Current Deferred Tax Liability was $58181.0 in Q4 2024, with the low at $58181.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 58,181.00 |
| Dec 31, 2024 | 58,181.00 |